Conclusions
- This is the first study comprehensively mapping XPO1 mRNA expression and immune-correlates in PDAC.
- We found that high XPO1 is linked to increased immune cell infiltration and more T cell-inflamed tumors.
- Our data provides a potential rationale to combine immune checkpoint therapy (+/- XPO1 inhibitors) in XPO1H PDACs.